Loading...
Loading...
Loading...
Gainers
- Athenex ATNX shares increased by 30.5% to $0.62 during Monday's pre-market session. The market value of their outstanding shares is at $69.1 million. As per the press release, Q1 earnings came out 4 days ago.
- Verastem VSTM stock rose 25.0% to $1.35. The company's market cap stands at $251.5 million.
- Cidara Therapeutics CDTX stock increased by 14.48% to $0.49. The company's market cap stands at $33.8 million. The company's, Q1 earnings came out 3 days ago.
- Genocea Biosciences GNCA shares moved upwards by 13.33% to $0.26. The company's market cap stands at $14.9 million.
- Phio Pharma PHIO shares increased by 13.07% to $0.8. The market value of their outstanding shares is at $10.9 million. The company's, Q1 earnings came out 2 days ago.
- Epizyme EPZM shares increased by 11.4% to $0.58. The market value of their outstanding shares is at $95.6 million. As per the press release, Q1 earnings came out 4 days ago.
Losers
- Chimerix CMRX stock decreased by 52.6% to $2.01 during Monday's pre-market session. The company's market cap stands at $175.7 million. As per the press release, Q1 earnings came out today.
- Valneva VALN stock fell 19.39% to $20.08. The company's market cap stands at $1.0 billion.
- Akebia Therapeutics AKBA shares fell 16.52% to $0.38. The market value of their outstanding shares is at $68.8 million.
- Immix Biopharma IMMX stock fell 15.71% to $1.1. The company's market cap stands at $15.2 million.
- Calithera Biosciences CALA stock declined by 15.61% to $0.19. The company's market cap stands at $21.7 million. As per the press release, Q1 earnings came out 4 days ago.
- Surgalign Holdings SRGA stock fell 14.29% to $0.16. The company's market cap stands at $31.0 million. The company's, Q1 earnings came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Loading...
Loading...
Loading...
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.